Advanced Research Center, Inc.

09/18/2026

Does your loved one struggle with schizophrenia symptoms?

A clinical research trial is enrolling adolescents aged 13–17 who have been diagnosed with schizophrenia.

To pre-qualify for this study, participants must:

✨Be 13 to 17 years of age
✨Have been diagnosed with schizophrenia
✨Be currently experiencing symptoms of psychosis
✨Be able to provide assent, and have a parent or guardian provide consent
✨Have been living in a stable environment for at least 28 days prior to screening and be expected to remain in the same living environment throughout the study.

Additional eligibility criteria may apply. To learn more and find out if you may qualify, please contact our study team at (714) 999-6688.

08/31/2026

Does your loved one experience agitation associated with Alzheimer's disease (AD)?

The Advanced Research Center is looking for adults aged 55 or older with Alzheimer's disease to participate in a clinical research study.

To pre-qualify for this study, participants must:
💚Be 55 years of age or older
💚Meet clinical criteria for Alzheimer's disease (AD)
💚Be experiencing symptoms of agitation associated with Alzheimer's disease
💚Have experienced symptoms of agitation for at least 2 weeks prior to screening
💚Have a caregiver who is willing and able to participate throughout the study
💚Have a body mass index (BMI) between 18 and 40 kg/m²

Additional eligibility criteria may apply. To learn more and find out if you may qualify, please contact our study team at (714) 999-6688.

📍Anaheim, California

08/14/2026

Have your schizophrenia symptoms changed recently? A clinical trial is enrolling adults aged 18–65 with a diagnosis of schizophrenia.

To pre-qualify for this study, participants must:
🩵 Be 18 to 65 years of age
🩵 Be willing to stay in the hospital during the study
🩵 Have a diagnosis of schizophrenia
🩵 Be currently experiencing worsening symptoms within the past 6 weeks, or have been hospitalized within the past 2 weeks

Additional eligibility criteria may apply. To learn more and find out if you may qualify, please contact our study team at (714) 999-6688.

📍Anaheim, California

08/04/2026

Have you noticed a loved one experiencing ongoing low mood or loss of interest? A clinical trial is enrolling adults aged 18–65 with major depressive disorder (MDD).

To pre-qualify for this study, participants must:
-Be 18 to 65 years of age
-Have a diagnosis of Major Depressive Disorder (MDD) with current moderate to severe depression
-Be currently experiencing a major depressive episode that has lasted at least 4 weeks but no longer than 6 months

Additional eligibility criteria may apply. To learn more and find out if you qualify, please contact our study team at (714) 999 6688.

Clinical research center dedicated to finding the most advanced treatment options

07/07/2026

Do you or a loved one struggle with depressive episodes associated with Bipolar I or II Disorder? A clinical trial is enrolling adults aged 18–65 with a diagnosis of Bipolar I or II Disorder (without psychotic features).

To pre-qualify for this study, participants must:

▪️Be 18 to 65 years of age
▪️Be diagnosed with Bipolar I or Bipolar II disorder (without psychotic features)
▪️Be currently experiencing a depressive episode that has lasted at least 4 weeks but no longer than 12 months
▪️Be willing and able to travel for and complete an eye examination

Additional eligibility criteria may apply. To learn more and find out if you qualify, please contact our study team at (714) 999 6688.

06/23/2026

Are you or someone close to you struggling with Generalized Anxiety Disorder (GAD)?

A clinical trial is currently enrolling adults between the ages of 18 and 65 who have been diagnosed with Generalized Anxiety Disorder (GAD).

To pre-qualify for this study, participants must:
-Be 18 to 65 years old with Generalized Anxiety Disorder (GAD)
-Be currently taking Paroxetine, Escitalopram, Duloxetine, Venlafaxine ER, Fluoxetine, Sertraline, Citalopram, Venlafaxine IR, Desvenlafaxine, Milnacipran, Vilazodone, Bupropion, Mirtazapine for at least 8 weeks
-Not be currently experiencing a depressive episode
-Have no lifetime history of schizophrenia, schizoaffective disorder, bipolar I or II disorder, posttraumatic stress disorder, or developmental/cognitive disorders

Additional eligibility criteria may apply. To learn more and find out if you qualify, please contact our study team at (714) 999 6688.

06/08/2026

Do you or a loved one struggle with depressive episodes from Bipolar Depression? A clinical research trial is enrolling adults aged 18–65 with a Bipolar Depression.

To pre-qualify for this study, participants must:
▪️Be 18 to 65 years of age
▪️Have a diagnosis of bipolar I or II disorder without psychotic
features
▪️Be currently experiencing a major depressive episode (MDE)
that began at least 4 weeks before consent and no more than
6 months prior screening
▪️Meet the following psychiatric history criteria:
- No psychiatric hospitalization within 3 months prior to
screening.
- No lifetime history for schizophrenia, other psychotic
disorders, or mood episodes with psychotic features.

Additional eligibility criteria may apply. To learn more and find out if you qualify, please contact our study team at (714) 999 6688.

Clinical research center dedicated to finding the most advanced treatment options

06/08/2026

Have you noticed a loved one experiencing ongoing low mood or loss of interest? A clinical trial is enrolling adults aged 18–65 with major depressive disorder (MDD).

To pre-qualify for this study, participants must:
▪️Be 18 to 65 years of age
▪️Be experiencing a major depressive episode lasting 4 weeks to
6 months
▪️Have not been hospitalized for psychiatric reasons in the past
3 months
▪️Have no history of psychotic or neurocognitive disorders

Additional eligibility criteria may apply. To learn more and find out if you qualify, please contact our study team at (714) 999 6688.

04/21/2026

Are you struggling with Irritable Bowel Syndrome with Constipation (IBS-C)? A clinical research trial is looking for adolescents 12 to 17 years of age with IBS-C to participate in our clinical research trials.

To pre-qualify for this study, participants must:
▪️Be 12 to 17 years old
▪️Weigh 18 kg or more at the time they provide written assent
▪️Have been diagnosed with Irritable Bowel Syndrome with Constipation (IBS-C)
▪️Be willing to stop current laxatives and use study-approved rescue medication
▪️Have a negative pregnancy test and use appropriate contraception

Additional eligibility criteria may apply. To learn more and find out if you qualify, please contact our study team at (714) 999-6688.

04/10/2026

If you or a loved one is struggling with bipolar I disorder, this study evaluating an investigational drug for children may be of interest.

To pre-qualify for this study, participants must:
-Be 10 to 17 years old.
-Have a diagnosis of bipolar I disorder (most recent episode depressed, with or without psychotic features.)
-Be currently experiencing a depressive episode.
-Have a lifetime history of at least one manic episode.
-Have a parent or legal representative who is willing and able to be responsible for your safety monitoring during the study.

Additional criteria may apply. Please contact the study team to confirm your eligibility at (714) 999 6688.